Amyloid-Beta-Targeted MAbs Have Little Impact in MCI, Mild Alzheimer Disease Dementia

Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity
Amyloid-Beta-Targeted MAbs Have Little Impact in MCI, Mild Alzheimer Disease Dementia
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on: 
Updated on: 
Loading content, please wait...